
借助处方前置审核系统实施含β-内酰胺酶抑制剂复合制剂精细化管理*
Fine Management of β-lactamase Inhibitor Compound Preparations Through the Pre-prescription Review System
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 |
|
〉 |